1 of 1
Story summary
- QuidelOrtho Corp is seeking to sell its point-of-care testing unit for $1.5 billion.
- Advent International, SK Capital Partners and Archimed have expressed interest in acquiring the unit.
- The unit accounted for 22 % of QuidelOrtho’s total revenues in 2025.
- Bloomberg data values QuidelOrtho at an enterprise value of $3.64 billion.
- QuidelOrtho, formed in 2022 by merging Quidel Corporation and Ortho Clinical Diagnostics, did not comment on the sale.
